Zevra Therapeutics (ZVRA) Change in Intangibles (2026)

Zevra Therapeutics (ZVRA) reported Change in Intangibles of $43.9 million for Q1 2026.

Zevra Therapeutics (ZVRA) Change in Intangibles (2026) Analysis & Trends

Zevra Therapeutics has reported Change in Intangibles for 1 years, with the latest figure at $43.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -2.96 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Zevra Therapeutics 704.96 Mn 504.34 Mn 34.30 Mn 43.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 43.94 Mn
Mar 31, 2026 43.94 Mn